Medunjanin, Senad <br/><br/>
DNA-dependent protein kinase (DNA-PK) permits vascular smooth muscle cell proliferation through phosphorylation of the orphan nuclear receptor NOR1.  [electronic resource] 

 -  Cardiovascular research  Jun 2015 
 - 488-97 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1755-3245 
<br/><br/><label>Standard No.: </label>10.1093/cvr/cvv126  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Atherosclerosis--enzymology<br/>Cell Proliferation--drug effects<br/>Cells, Cultured<br/>Cyclin D1--metabolism<br/>DNA-Activated Protein Kinase--antagonists & inhibitors<br/>DNA-Binding Proteins--antagonists & inhibitors<br/>Disease Models, Animal<br/>Enzyme Inhibitors--pharmacology<br/>Femoral Artery--drug effects<br/>Humans<br/>Male<br/>Membrane Transport Proteins--genetics<br/>Mice, Inbred C57BL<br/>Muscle, Smooth, Vascular--drug effects<br/>Myocytes, Smooth Muscle--drug effects<br/>Neointima<br/>Nuclear Proteins--antagonists & inhibitors<br/>Phosphorylation<br/>Proliferating Cell Nuclear Antigen--metabolism<br/>Protein Stability<br/>Proteolysis<br/>RNA Interference<br/>Retinoblastoma Protein--metabolism<br/>Signal Transduction<br/>Time Factors<br/>Transfection<br/>Ubiquitination<br/>Vascular Remodeling--drug effects<br/>Vascular System Injuries--drug therapy